Minerva Surgical, Inc. (UTRS)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Nov 13, 2024

Minerva Surgical Statistics

Total Valuation

Minerva Surgical has a market cap or net worth of 9. The enterprise value is 32.43 million.

Market Cap 9
Enterprise Value 32.43M

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

Minerva Surgical has 8.88 million shares outstanding.

Current Share Class n/a
Shares Outstanding 8.88M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.27%
Owned by Insiders (%) 0.40%
Owned by Institutions (%) n/a
Float 2.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.97
EV / Sales 0.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.84

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 2.15.

Current Ratio 1.88
Quick Ratio 0.88
Debt / Equity 2.15
Debt / EBITDA n/a
Debt / FCF -1.12
Interest Coverage -7.79

Financial Efficiency

Return on equity (ROE) is -160.07% and return on invested capital (ROIC) is -34.21%.

Return on Equity (ROE) -160.07%
Return on Assets (ROA) -27.35%
Return on Capital (ROIC) -34.21%
Revenue Per Employee 297,086
Profits Per Employee -192,241
Employee Count 174
Asset Turnover 0.66
Inventory Turnover 1.35

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -100.00% in the last 52 weeks. The beta is 4.58, so Minerva Surgical's price volatility has been higher than the market average.

Beta (5Y) 4.58
52-Week Price Change -100.00%
50-Day Moving Average 0.47
200-Day Moving Average 2.31
Relative Strength Index (RSI) 18.49
Average Volume (20 Days) 2,845

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.25

Income Statement

In the last 12 months, Minerva Surgical had revenue of 51.69 million and -33.45 million in losses. Loss per share was -5.38.

Revenue 51.69M
Gross Profit 28.01M
Operating Income -34.26M
Pretax Income -33.40M
Net Income -33.45M
EBITDA -25.56M
EBIT -34.26M
Loss Per Share -5.38
Full Income Statement

Balance Sheet

The company has 11.13 million in cash and 43.55 million in debt, giving a net cash position of -32.43 million or -3.65 per share.

Cash & Cash Equivalents 11.13M
Total Debt 43.55M
Net Cash -32.43M
Net Cash Per Share -3.65
Equity (Book Value) 20.26M
Book Value Per Share 2.28
Working Capital 18.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.73 million and capital expenditures -53,000, giving a free cash flow of -38.79 million.

Operating Cash Flow -38.73M
Capital Expenditures -53,000
Free Cash Flow -38.79M
FCF Per Share -4.37
Full Cash Flow Statement

Margins

Gross margin is 54.18%, with operating and profit margins of -66.27% and -64.71%.

Gross Margin 54.18%
Operating Margin -66.27%
Pretax Margin -64.61%
Profit Margin -64.71%
EBITDA Margin -49.45%
EBIT Margin -66.27%
FCF Margin -75.03%

Dividends & Yields

Minerva Surgical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -363.35%
Shareholder Yield -363.35%
Earnings Yield -537,604,400.00%
FCF Yield -436,849,037.38%

Stock Splits

The last stock split was on October 2, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date Oct 2, 2023
Split Type Reverse
Split Ratio 0.05

Scores

Minerva Surgical has an Altman Z-Score of -6.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.14
Piotroski F-Score n/a